Hepatitis B trials in India

1 of 1 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.

  Where

  New Delhi

  Age

  18 years to 70 years

  People

  200

  Run by

  Institute of Liver and Biliary Sciences, India

  See details and how to joinNCT05195450